SCHEDULE: Federated Hermes Amends Arcturus Therapeutics Stake

Federated Hermes, Inc. and related entities filed an amendment to their Schedule 13G, disclosing a continued beneficial ownership of 11.63% in Arcturus Therapeutics Holdings Inc.

Summary

• Federated Hermes, Inc., along with the Voting Shares Irrevocable Trust and the Donahue family (Thomas R., Ann C., and J. Christopher), filed an Amendment No. 3 to Schedule 13G.
• The filing reports beneficial ownership of 3,303,640 shares of common stock in Arcturus Therapeutics Holdings Inc.
• This represents 11.63% of the class of securities.
• Federated Hermes, Inc. and the Voting Shares Irrevocable Trust hold sole voting and dispositive power over these shares.
• Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue hold shared voting and dispositive power over the same 3,303,640 shares.
• The reporting persons explicitly disclaim beneficial ownership of these securities, stating the report should not be construed as an admission of such ownership, as the shares are held by managed funds advised by Federated Hermes subsidiaries.

Sentiment

Score: 5

Explanation: The filing is a routine disclosure of beneficial ownership, indicating a neutral sentiment. It confirms a significant institutional stake but provides no new operational or financial information about the issuer.

Positives

• Continued significant institutional ownership (11.63%) by Federated Hermes and related entities, indicating a sustained investment interest in Arcturus Therapeutics.

Future Outlook

NA

Management Comments

• In accordance with Rule 13d-4 under the Exchange Act, Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue declare that this report should not be construed as an admission that any of them is the beneficial owner of the securities held by any of the Managed Funds, and each of Federated Hermes, Inc.; the Voting Shares Irrevocable Trust; Thomas R. Donahue; Ann C. Donahue; and J. Christopher Donahue expressly disclaim beneficial ownership of such securities.

Industry Context

NA

Related Party Transactions

• The filing details the relationship where Federated Hermes, Inc. is the parent holding company of investment advisers to funds owning the shares.
• All voting stock of Federated Hermes, Inc. is held by the Voting Shares Irrevocable Trust, for which Thomas R. Donahue, Ann C. Donahue, and J. Christopher Donahue act as trustees.
• These individuals and the Trust are filing jointly due to their collective voting control over Federated Hermes, Inc.

Stakeholder Impact

• Shareholders: Provides transparency regarding a significant institutional shareholder's stake, which can influence market perception and potentially provide a level of stability or oversight.

Key Dates

Keywords

Arcturus Therapeutics, Federated Hermes, Schedule 13G, Beneficial Ownership, Institutional Investor, Common Stock, Equity Stake, Investment Management